| Lisa Rider, MD | |
|
Clinical Research Ctr, 10 Center Drive, Bethesda, MD 20892-0001 | |
| (301) 496-1211 | |
| Not Available |
| Full Name | Lisa Rider |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Pediatric Rheumatology |
| Location | Clinical Research Ctr, Bethesda, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669566691 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0216X | Pediatrics - Pediatric Rheumatology | MD035811 (District Of Columbia) | Secondary |
| 2080P0216X | Pediatrics - Pediatric Rheumatology | D46950 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lisa Rider, MD Niehs Nih, Crc 4-2352, Msc 1301, 10 Center Drive, Bethesda, MD 20892-0001 Ph: (301) 451-6272 | Lisa Rider, MD Clinical Research Ctr, 10 Center Drive, Bethesda, MD 20892-0001 Ph: (301) 496-1211 |
News Archive
Doctors at the Universities of Nottingham and Leicester are collaborating in the use of a magnetic resonance technique to image and quantify the air spaces inside the lungs - and the results of their research may lead to a link between childhood disease and later degenerative lung disease.
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the Food and Drug Administration (FDA) has accepted for filing and designated for Priority Review the Company's New Drug Application (NDA) for rifaximin tablets 550 mg for the maintenance of remission of hepatic encephalopathy (HE). Additionally, the FDA has informed the Company of its plan to schedule an Advisory Committee meeting in late February 2010 to discuss the application.
Replacing one amino acid on the surface of a virus that shepherds corrective genes into cells could be the breakthrough scientists have needed to make gene therapy a more viable option for treating genetic diseases such as hemophilia, University of Florida researchers say.
Ending Preventable Maternal Mortality is a global initiative with the ultimate goal of ending preventable maternal mortality to support achievement of Sustainable Development Goals targets to attain an average global maternal mortality ratio of less than 70 per 100 000 live births by 2030.
› Verified 6 days ago
Dr. Richard Zanetti Jr., MD Pediatrics Medicare: Medicare Enrolled Practice Location: 8091 Rockville Pike, Bethesda, MD 20889 Phone: 301-400-1664 | |
Dr. Ellen Werber Leschek, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 9000 Rockville Pike, National Institutes Of Health - Clinical Center, Pediat, Bethesda, MD 20892 Phone: 301-451-9229 | |
Dr. Daniel Victor-calvin Hammond, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 8901 Wisonsin Ave, Bethesda, MD 20889 Phone: 301-295-4959 | |
Dr. Ann Talbot Schwartz, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 8901 Wisconsin Ave, Bethesda, MD 20889 Phone: 301-295-4941 | |
Dr. Rhett Allen Barrett, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 8901 Wisconsin Ave, Bethesda, MD 20889 Phone: 301-295-4900 Fax: 301-319-1940 | |
Dr. Paul Meltzer, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 10 Center Dr, Bethesda, MD 20892 Phone: 301-318-2421 | |
Dr. James M Woodworth, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8901 Wisconsin Ave, Bethesda, MD 20889 Phone: 301-295-4611 |